Gene · 344
Papers3,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia. | J Clin Lipidol | 2024 | 37981531 | PubTator, text mining | PubMed |
| TargetGene: a comprehensive database of cell-type-specific target genes for genetic variants. | Nucleic Acids Res | 2024 | 37870478 | PubTator, text mining | PubMed |
| A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes. | Protein Cell | 2024 | 37378670 | PubTator, text mining | PubMed |
| TOmicsVis: An all-in-one transcriptomic analysis and visualization R package with Shinyapp interface. | Imeta | 2023 | 38868229 | PubTator, text mining | PubMed |
| Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis increasing the risk of cerebrovascular complications. | Nat Cardiovasc Res | 2023 | 38362263 | PubTator, text mining | PubMed |
| The chylomicron saga: time to focus on postprandial metabolism. | Front Endocrinol (Lausanne) | 2023 | 38303975 | PubTator, text mining | PubMed |
| DNAJC8: a prognostic marker and potential therapeutic target for hepatocellular carcinoma. | Front Immunol | 2023 | 38274804 | PubTator, text mining | PubMed |
| Diagnosis of Familial Hypercholesterolemia in Children and Young Adults. | Int J Mol Sci | 2023 | 38203485 | PubTator, text mining | PubMed |
| The analysis of serum lipids profile in Guillain-Barre syndrome. | Front Immunol | 2023 | 38143756 | PubTator, text mining | PubMed |
| Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment. | J Transl Med | 2023 | 38115108 | PubTator, text mining | PubMed |
| Developing a model to predict the early risk of hypertriglyceridemia based on inhibiting lipoprotein lipase (LPL): a translational study. | Sci Rep | 2023 | 38114521 | PubTator, text mining | PubMed |
| Altered Metabolism and DAM-signatures in Female Brains and Microglia with Aging. | bioRxiv | 2023 | 38076915 | PubTator, text mining | PubMed |
| The Role of Apolipoproteins in the Commonest Cancers: A Review. | Cancers (Basel) | 2023 | 38067270 | PubTator, text mining | PubMed |
| KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN. | Heliyon | 2023 | 38058614 | PubTator, text mining | PubMed |
| Accurate and efficient estimation of local heritability using summary statistics and the linkage disequilibrium matrix. | Nat Commun | 2023 | 38040712 | PubTator, text mining | PubMed |
| Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2023 | 38034020 | PubTator, text mining | PubMed |
| Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment. | Lipids Health Dis | 2023 | 38031159 | PubTator, text mining | PubMed |
| The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. | Front Endocrinol (Lausanne) | 2023 | 38027131 | PubTator, text mining | PubMed |
| Loss-of-Function Homozygous Variant in LPL Causes Type I Hyperlipoproteinemia and Renal Lipidosis. | Kidney Int Rep | 2023 | 38025240 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields novel macrophage-secreted drivers of invasion. | bioRxiv | 2023 | 38014161 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/344/papers?page=8